BENZYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER-HYDROCHLORIDE
Compound with spectra: 1 NMR
![BENZYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER-HYDROCHLORIDE](/api/compound/EjNLeNEa8Pz.png?ph=true&h=300&w=458 "BENZYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER-HYDROCHLORIDE")
| SpectraBase Compound ID | EjNLeNEa8Pz |
|---|---|
| InChI | InChI=1S/C19H27N3O6.ClH/c1-22(12-18(25)28-13-14-6-4-3-5-7-14)17(24)9-8-15(19(26)27-2)21-16(23)10-11-20;/h3-7,15H,8-13,20H2,1-2H3,(H,21,23);1H/t15-;/m1./s1 |
| InChIKey | GIKYQYAWGDTLNW-XFULWGLBSA-N |
| Mol Weight | 429.9 g/mol |
| Molecular Formula | C19H28ClN3O6 |
| Exact Mass | 429.166663 g/mol |
| Parent InChIKey | PWJAOEGVEUXWEM-OAHLLOKOSA-N |
| Enantiomer InChIKey | GIKYQYAWGDTLNW-RSAXXLAASA-N |
| Racemate InChIKey | GIKYQYAWGDTLNW-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
BENZYL-N-(TERT.-BUTOXYCARBONYL)-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-ESTER
L-N,N-SUCCINYLDIGLUTAMIC ACID, TETRABENZYL ESTER
Dibenzyl 2-([(benzyloxy)carbonyl]amino)pentanedioate
N-ACETYL-N(DELTA)-BENZYLOXYCARBONYL-L-ORNITHINYL-L-ALANINE-METHYLESTER
(2S)-2-(tert-butoxycarbonylamino)-5-cyclopentyl-5-keto-valeric acid benzyl ester
DLWZEGALKAGTLJ-UHFFFAOYSA-N
1-(2-Methyl-2-propenyl)-5-carbethoxy-2-pyrrolidinone
1-Benzyl 6-Methyl- 2(S)-[(tert-Butoxycarbonyl)amino]-5-methylidenehexanedioate
L-N-[p-(BENZYLOXY)-alpha-CARBOXYPHENETHYL] SUCCINIC ACID, alpha-METHYL ESTER
T-Butoxycarbonyl-lysyl(T-butoxycarbonyl)-glycine benzyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |